The global biopsy devices market size is projected to reach USD 3.64 billion by 2030, expanding at a CAGR of 7.1% from 2023 to 2030. Introduction of technologically advanced products, leading to increasing adoption of minimally invasive surgical procedures, is the key factor driving the market.
In addition, growing investments in the oncology field by government and non-government organizations are expected to positively impact market growth. For instance, in 2022, the American Institute for Cancer Research funded more than $110 million for research to ensure a future without cancer. Moreover, the organization supports the establishment of an Advanced Research Projects Agency for Health (ARPA-H) that is focused on accelerating cancer and biomedical research translation.
The COVID-19 pandemic led to a significant drop in biopsy procedures, especially in the first half of the pandemic. This represented a temporary negative impact on the sales of biopsy devices. The major factor responsible for this moderate downfall in sales was reduced patient visits to healthcare institutes as a precautionary measure to avoid being infected with the virus.
With economies returning to normalcy and the healthcare sector going back to majorly focusing on cancer research, the market recovered at a rapid pace. The biopsy market is further expected to witness significant growth over the forecast period due to constant advancements in the field of oncology and diagnostics.
This product will be delivered within 1-3 business days.
In addition, growing investments in the oncology field by government and non-government organizations are expected to positively impact market growth. For instance, in 2022, the American Institute for Cancer Research funded more than $110 million for research to ensure a future without cancer. Moreover, the organization supports the establishment of an Advanced Research Projects Agency for Health (ARPA-H) that is focused on accelerating cancer and biomedical research translation.
The COVID-19 pandemic led to a significant drop in biopsy procedures, especially in the first half of the pandemic. This represented a temporary negative impact on the sales of biopsy devices. The major factor responsible for this moderate downfall in sales was reduced patient visits to healthcare institutes as a precautionary measure to avoid being infected with the virus.
With economies returning to normalcy and the healthcare sector going back to majorly focusing on cancer research, the market recovered at a rapid pace. The biopsy market is further expected to witness significant growth over the forecast period due to constant advancements in the field of oncology and diagnostics.
Biopsy Devices Market Report Highlights
- Needle-based biopsy guns held the largest market share in 2022 owing to surging demand for these devices to acquire samples from soft tissues
- New product launches of vacuum-assisted biopsy devices are further expected to accelerate the demand for needle-based biopsy guns over the forecast period
- The biopsy needles segment is expected to register a significant CAGR over the forecast period. It represents lucrative growth opportunities owing to the increasing adoption of these products and the launch of advanced products
- North America dominated the market in 2022 due to the high penetration rate of technologically advanced products and the presence of key market players in the region
- The rising incidence of cancer coupled with high unmet patient needs is expected to propel the growth of the market extensively in the Asia Pacific region
This product will be delivered within 1-3 business days.
Table of Contents
Chapter 1. Methodology and Scope1.1. Market Segmentation & Scope
1.1.1. Product
1.1.2. Regional scope
1.1.3. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.3.5.1. Data for primary interviews in North America
1.3.5.2. Data for primary interviews in Europe
1.3.5.3. Data for primary interviews in Asia Pacific
1.3.5.4. Data for primary interviews in Latin America
1.3.5.5. Data for Primary interviews in MEA
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity flow analysis (Model 1)
1.6.2. Approach 1: Commodity flow approach
1.6.3. Volume price analysis (Model 2)
1.6.4. Approach 2: Volume price analysis
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
1.9.1. Objective 1
1.9.2. Objective 2
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Product Outlook
2.2.2. Regional Outlook
2.3. Competitive Insights
Chapter 3. Biopsy Devices Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Industry Value Chain Analysis
3.3.1. Reimbursement framework
3.4. Market Dynamics
3.4.1. Market driver analysis
3.4.1.1. Increasing prevalence of cancer
3.4.1.2. Growing demand for minimally invasive medical procedures
3.4.1.3. New product launches
3.4.2. Market restraint analysis
3.4.2.1. High cost of products
3.5. Biopsy Devices Market Analysis Tools
3.5.1. Industry Analysis - Porter’s
3.5.1.1. Supplier power
3.5.1.2. Buyer power
3.5.1.3. Substitution threat
3.5.1.4. Threat of new entrant
3.5.1.5. Competitive rivalry
3.5.2. PESTEL Analysis
3.5.2.1. Political landscape
3.5.2.2. Technological landscape
3.5.2.3. Economic landscape
3.5.3. Major Deals & Strategic Alliances Analysis
3.5.4. Market Entry Strategies
Chapter 4. Biopsy Devices: Product Estimates & Trend Analysis
4.1. Definitions and Scope
4.1.1. Needle-based Biopsy Guns
4.1.2. Biopsy Guidance Systems
4.1.3. Biopsy Needles
4.1.4. Biopsy Forceps
4.1.5. Others
4.2. Product Market Share, 2022& 2030
4.3. Segment Dashboard
4.4. Global Biopsy Devices Market by Product Outlook
4.5. Market Product& Forecasts and Trend Analyses, 2018 to 2030 for the following
4.5.1. Needle-based Biopsy Guns
4.5.1.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Million)
4.5.1.2. Vacuum-assisted Biopsy (VAB) Devices
4.5.1.2.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Million)
4.5.1.3. Fine Needle Aspiration Biopsy (FNAB) Devices
4.5.1.3.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Million)
4.5.1.4. Core Needle Biopsy (CNB) devices
4.5.1.4.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Million)
4.5.2. Biopsy Guidance Systems
4.5.2.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Million)
4.5.2.2. Manual
4.5.2.2.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Million)
4.5.2.3. Robotic
4.5.2.3.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Million)
4.5.3. Biopsy Needles
4.5.3.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Million)
4.5.3.2. Disposable
4.5.3.2.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Million)
4.5.3.3. Reusable
4.5.3.3.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Million)
4.5.4. Biopsy Forceps
4.5.4.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Million)
4.5.4.2. General Biopsy Forceps
4.5.4.2.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Million)
4.5.4.3. Hot Biopsy Forceps
4.5.4.3.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Million)
4.5.5. Others
4.5.5.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Million)
4.5.5.2. Brushes
4.5.5.2.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Million)
4.5.5.3. Curettes
4.5.5.3.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Million)
4.5.5.4. Punches
4.5.5.4.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Million)
Chapter 5. Biopsy Devices Market: Regional Estimates & Trend Analysis
5.1. Regional market share analysis, 2022& 2030
5.2. Regional Market Dashboard
5.3. Global Regional Market Snapshot
5.4. Regional Market Share and Leading Players, 2022
5.4.1. North America
5.4.2. Europe
5.4.3. Asia Pacific
5.4.4. Latin America
5.4.5. Middle East and Africa
5.5. SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
5.5.1. North America
5.5.2. Europe
5.5.3. Asia Pacific
5.5.4. Latin America
5.5.5. Middle East and Africa
5.6. Market Product, & Forecasts and Trend Analysis, 2018 to 2030
5.7. North America
5.7.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
5.7.2. U.S.
5.7.2.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
5.7.3. Canada
5.7.3.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
5.8. Europe
5.8.1. U.K.
5.8.1.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
5.8.2. Germany
5.8.2.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
5.8.3. France
5.8.3.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
5.8.4. Italy
5.8.4.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
5.8.5. Spain
5.8.5.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
5.8.6. Denmark
5.8.6.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
5.8.7. Sweden
5.8.7.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
5.8.8. Norway
5.8.8.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
5.9. Asia Pacific
5.9.1. Japan
5.9.1.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
5.9.2. India
5.9.2.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
5.9.3. China
5.9.3.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
5.9.4. South Korea Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
5.9.5. Thailand Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
5.9.6. Australia Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
5.10. Latin America
5.10.1. Brazil
5.10.1.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
5.10.2. Mexico
5.10.2.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
5.10.3. Argentina
5.10.3.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
5.11. MEA
5.11.1. South Africa
5.11.1.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
5.11.2. Saudi Arabia
5.11.2.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
5.11.3. UAE
5.11.3.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
5.11.4. Kuwait
5.11.4.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
Chapter 6. Competitive Landscape
6.1. Recent Developments & Impact Analysis, By Key Market Participants
6.2. Company/Competition Categorization
6.2.1. Innovators
6.2.2. Market Leaders
6.2.3. Emerging Players
6.3. Vendor Landscape
6.3.1. List of key distributors and channel partners
6.3.2. Key customers
6.3.3. Key company market share analysis, 2022
6.3.4. Cardinal Health Inc.
6.3.4.1. Company overview
6.3.4.2. Financial performance
6.3.4.3. Product benchmarking
6.3.4.4. Strategic initiatives
6.3.5. Hologic, Inc.
6.3.5.1. Company overview
6.3.5.2. Financial performance
6.3.5.3. Product benchmarking
6.3.5.4. Strategic initiatives
6.3.6. Danaher Corporation
6.3.6.1. Company overview
6.3.6.2. Financial performance
6.3.6.3. Product benchmarking
6.3.6.4. Strategic initiatives
6.3.7. CONMED Corporation
6.3.7.1. Overview
6.3.7.2. Financial performance
6.3.7.3. Product benchmarking
6.3.7.4. Strategic initiatives
6.3.8. Cook Medical
6.3.8.1. Company overview
6.3.8.2. Financial performance
6.3.8.3. Product benchmarking
6.3.8.4. Strategic initiatives
6.3.9. DTR Medical
6.3.9.1. Company overview
6.3.9.2. Financial performance
6.3.9.3. Product benchmarking
6.3.9.4. Strategic initiatives
6.3.10. INRAD, Inc.
6.3.10.1. Company overview
6.3.10.2. Financial performance
6.3.10.3. Product benchmarking
6.3.10.4. Strategic initiatives
6.3.11. Devicor Medical Products Inc.
6.3.11.1. Company overview
6.3.11.2. Financial performance
6.3.11.3. Product benchmarking
6.3.11.4. Strategic initiatives
6.3.12. Gallini Srl
6.3.12.1. Company overview
6.3.12.2. Financial performance
6.3.12.3. Product benchmarking
6.3.12.4. Strategic initiatives
6.3.13. TransMed7, LLC
6.3.13.1. Company overview
6.3.13.2. Financial performance
6.3.13.3. Product benchmarking
6.3.13.4. Strategic initiatives
List of Tables
Table 1 List of Abbreviation
Table 2 North America biopsy devices market, by region, 2018 - 2030 (USD Million)
Table 3 North America biopsy devices market, by product, 2018 - 2030 (USD Million)
Table 4 U.S. biopsy devices market, by product, 2018 - 2030 (USD Million)
Table 5 Canada biopsy devices market, by product, 2018 - 2030 (USD Million)
Table 6 Europe biopsy devices market, by region, 2018 - 2030 (USD Million)
Table 7 Europe biopsy devices market, by product, 2018 - 2030 (USD Million)
Table 8 Germany biopsy devices market, by product, 2018 - 2030 (USD Million)
Table 9 U.K. biopsy devices market, by product, 2018 - 2030 (USD Million)
Table 10 France biopsy devices market, by product, 2018 - 2030 (USD Million)
Table 11 Italy biopsy devices market, by product, 2018 - 2030 (USD Million)
Table 12 Spain biopsy devices market, by product, 2018 - 2030 (USD Million)
Table 13 Denmark biopsy devices market, by product, 2018 - 2030 (USD Million)
Table 14 Sweden biopsy devices market, by product, 2018 - 2030 (USD Million)
Table 15 Norway biopsy devices market, by product, 2018 - 2030 (USD Million)
Table 16 APAC biopsy devices market, by region, 2018 - 2030 (USD Million)
Table 17 APAC biopsy devices market, by product, 2018 - 2030 (USD Million)
Table 18 Japan biopsy devices market, by product, 2018 - 2030 (USD Million)
Table 19 India biopsy devices market, by product, 2018 - 2030 (USD Million)
Table 20 China biopsy devices market, by product, 2018 - 2030 (USD Million)
Table 21 South Korea biopsy devices market, by product, 2018 - 2030 (USD Million)
Table 22 Thailand biopsy devices market, by product, 2018 - 2030 (USD Million)
Table 23 Australia biopsy devices market, by product, 2018 - 2030 (USD Million)
Table 24 Latin America biopsy devices market, by region, 2018 - 2030 (USD Million)
Table 25 Latin America biopsy devices market, by product, 2018 - 2030 (USD Million)
Table 26 Brazil biopsy devices market, by product, 2018 - 2030 (USD Million)
Table 27 Mexico biopsy devices market, by product, 2018 - 2030 (USD Million)
Table 28 Argentina biopsy devices market, by product, 2018 - 2030 (USD Million)
Table 29 Middle East and Africa biopsy devices market, by region, 2018 - 2030 (USD Million)
Table 30 Middle East and Africa biopsy devices market, by product, 2018 - 2030 (USD Million)
Table 31 South Africa biopsy devices market, by product, 2018 - 2030 (USD Million)
Table 32 Saudi Arabia biopsy devices market, by product, 2018 - 2030 (USD Million)
Table 33 UAE biopsy devices market, by product, 2018 - 2030 (USD Million)
Table 34 Kuwait biopsy devices market, by product, 2018 - 2030 (USD Million)
List of Figures
FIG. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Primary interviews in North America
Fig. 5 Primary interviews in Europe
Fig. 6 Primary interviews in APAC
Fig. 7 Primary interviews in Latin America
Fig. 8 Primary interviews in MEA
Fig. 9 Market research approaches
Fig. 10 Value-chain-based sizing & forecasting
Fig. 11 QFD modeling for market share assessment
Fig. 12 Market formulation & validation
Fig. 13 Biopsy devices: market outlook
Fig. 14 Biopsy devices market competitive insights
Fig. 15 Parent market outlook
Fig. 16 Related/ancillary market outlook
Fig. 17 Penetration and growth prospect mapping
Fig. 18 Industry value chain analysis
Fig. 19 Biopsy devices market driver impact
Fig. 20 Biopsy devices market restraint impact
Fig. 21 Biopsy devices market strategic initiatives analysis
Fig. 22 Biopsy devices market: product movement analysis
Fig. 23 Biopsy devices market: product outlook and key takeaways
Fig. 24 Needle-based biopsy guns estimates and forecast, 2018 - 2030
Fig. 25 Vacuum-assisted biopsy (VAB) devices estimates and forecast, 2018 - 2030
Fig. 26 Fine needle aspiration biopsy (FNAB) devices estimates and forecast, 2018 - 2030
Fig. 27 Core needle biopsy (CNB) devices estimates and forecast, 2018 - 2030
Fig. 28 Biopsy guidance systems estimates and forecast, 2018 - 2030
Fig. 29 Manual guidance systems estimates and forecast, 2018 - 2030
Fig. 30 Robotic guidance systems estimates and forecast, 2018 - 2030
Fig. 31 Biopsy needles estimates and forecast, 2018 - 2030
Fig. 32 Disposable needles estimates and forecast, 2018 - 2030
Fig. 33 Reusable needles estimates and forecast, 2018 - 2030
Fig. 34 Biopsy forceps estimates and forecast, 2018 - 2030
Fig. 35 General biopsy forceps estimates and forecast, 2018 - 2030
Fig. 36 Hot biopsy forceps estimates and forecast, 2018 - 2030
Fig. 37 Others estimates and forecast, 2018 - 2030
Fig. 38 Brushes market: regional movement analysis
Fig. 39 Curettes estimates and forecast, 2018 - 2030
Fig. 40 Punches estimates and forecast, 2018 - 2030
Fig. 41 Global Biopsy devices market: regional outlook and key takeaways
Fig. 42 Global market share and leading players
Fig. 43 North America market share and leading players
Fig. 44 Europe market share and leading players
Fig. 45 Asia Pacific market share and leading players
Fig. 46 Latin America market share and leading players
Fig. 47 Middle East & Africa market share and leading players
Fig. 48 North America: SWOT
Fig. 49 Europe SWOT
Fig. 50 Asia Pacific SWOT
Fig. 51 Latin America SWOT
Fig. 52 MEA SWOT
Fig. 53 North America, by country
Fig. 54 North America
Fig. 55 North America market estimates and forecast, 2018 - 2030
Fig. 56 U.S.
Fig. 57 U.S. market estimates and forecast, 2018 - 2030
Fig. 58 Canada
Fig. 59 Canada market estimates and forecast, 2018 - 2030
Fig. 60 Europe
Fig. 61 Europe market estimates and forecast, 2018 - 2030
Fig. 62 U.K.
Fig. 63 U.K. market estimates and forecast, 2018 - 2030
Fig. 64 Germany
Fig. 65 Germany market estimates and forecast, 2018 - 2030
Fig. 66 France
Fig. 67 France market estimates and forecast, 2018 - 2030
Fig. 68 Italy
Fig. 69 Italy market estimates and forecast, 2018 - 2030
Fig. 70 Spain
Fig. 71 Spain market estimates and forecast, 2018 - 2030
Fig. 72 Denmark
Fig. 73 Denmark market estimates and forecast, 2018 - 2030
Fig. 74 Sweden
Fig. 75 Sweden market estimates and forecast, 2018 - 2030
Fig. 76 Norway
Fig. 77 Norway market estimates and forecast, 2018 - 2030
Fig. 78 Asia Pacific
Fig. 79 Asia Pacific market estimates and forecast, 2018 - 2030
Fig. 80 Japan
Fig. 81 Japan market estimates and forecast, 2018 - 2030
Fig. 82 India
Fig. 83 India market estimates and forecast, 2018 - 2030
Fig. 84 China
Fig. 85 China market estimates and forecast, 2018 - 2030
Fig. 86 South Korea
Fig. 87 South Korea market estimates and forecast, 2018 - 2030
Fig. 88 Thailand
Fig. 89 Thailand market estimates and forecast, 2018 - 2030
Fig. 90 Australia
Fig. 91 Australia market estimates and forecast, 2018 - 2030
Fig. 92 Latin America
Fig. 93 Latin America market estimates and forecast, 2018 - 2030
Fig. 94 Brazil
Fig. 95 Brazil market estimates and forecast, 2018 - 2030
Fig. 96 Mexico
Fig. 97 Mexico market estimates and forecast, 2018 - 2030
Fig. 98 Argentina
Fig. 99 Argentina market estimates and forecast, 2018 - 2030
Fig. 100 Middle East and Africa
Fig. 101 Middle East and Africa market estimates and forecast, 2018 - 2030
Fig. 102 South Africa
Fig. 103 South Africa market estimates and forecast, 2018 - 2030
Fig. 104 Saudi Arabia
Fig. 105 Saudi Arabia market estimates and forecast, 2018 - 2030
Fig. 106 UAE
Fig. 107 UAE market estimates and forecast, 2018 - 2030
Fig. 108 Kuwait
Fig. 109 Kuwait market estimates and forecast, 2018 - 2030
Fig. 110 Participant categorization- Biopsy devices market
Fig. 111 Market share of key market players - Biopsy devices market
Companies Mentioned
- Cardinal Health Inc.
- Hologic, Inc.
- Danaher Corporation
- CONMED Corporation
- Cook Medical
- DTR Medical
- INRAD, Inc.
- Devicor Medical Products Inc.
- Gallini Srl
- TransMed7, LLC
Methodology
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 120 |
| Published | December 2022 |
| Forecast Period | 2023 - 2030 |
| Estimated Market Value ( USD | $ 2.25 Billion |
| Forecasted Market Value ( USD | $ 3.64 Billion |
| Compound Annual Growth Rate | 7.1% |
| Regions Covered | Global |
| No. of Companies Mentioned | 10 |
